Congenital pseudarthrosis of the tibia can be challenging to treat. A study from 2021 states that, on average, only 50% of surgical procedures for the condition resulted in healing without ...

Congenital Pseudarthrosis of the Tibia (CPT) is a very rare, debilitating and devastating condition. Its incidence is reported to be between 1:140,000 to 1:250,000 live births. Treatment of CPT is ...

in its Phase 1b/2a clinical trial treating four patients with Congenital Pseudarthrosis of Tibia (CPT). Novadip is developing NVD-003, an autologous therapy derived from adipose stem cells (ASC ...

For months, 11-year-old Amit Vigoda has wanted just one thing: to have his right leg amputated. And after a very long decision making process, Amit’s mother and father have agreed to make their ...

“Congenital pseudarthrosis of the fibula is not an uncommon condition to accompany congenital pseudarthrosis of the tibia.” The study looks further into the results of a pedicled periosteal propeller ...

Therefore, the classic term congenital tibial pseudarthrosis used so often in the genetics and orthopedic literature is not the most appropriate term for this progressive process involving the ...

an autologous therapy derived from adipose stem cells as a potential single treatment to save limbs and restore mobility in patients with congenital pseudarthrosis of the tibia (CPT), a rare ...

This study was primarily intended to generate safety data in adults prior to initiating pediatric clinical development for the treatment of congenital pseudarthrosis of the tibia, a rare condition ...

A local Cherry Street Elementary student suffers from NF Type 1 Congenital Pseudarthrosis. In other words, her body thinks there's supposed to be a joint in her tibia where it shouldn't.

Congenital pseudarthrosis of the tibia, or CPT, is a devastating diagnosis. Impacting patients in just .5-3.5 in 150,000 1,2,3 live births, the condition is very rare and debilitating. Treatment ...